Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR

Clinical trial NCT00938613 · COMPLETED

Trial details

NCT number: NCT00938613
Sponsor: Ligand Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2007-02-01
Primary completion: 2007-04-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.